Premium
ADJUVANT SYSTEMIC THERAPY IN “EARLY” BREAST CANCER
Author(s) -
Cant Elizabeth L. McK.
Publication year - 1976
Publication title -
australian and new zealand journal of surgery
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.111
H-Index - 51
eISSN - 1445-2197
pISSN - 0004-8682
DOI - 10.1111/j.1445-2197.1976.tb03247.x
Subject(s) - medicine , systemic therapy , breast cancer , adjuvant , adjuvant therapy , mastectomy , systemic disease , cancer , disease , oncology , surgery
“Early” breast cancer is a systemic disease in the majority of cases. Progress has been and is being made toward the determination of those women at risk of recurrence. Attractive as it seems, the value of systemic adjuvant therapy, given at the time of minimal tumour load, i.e., after mastectomy, is not proven. Therefore, for the average case it is better to treat the cancer locally and to observe and leave further evaluation of systemic therapy to those centres which are able to conduct controlled, randomized trials.